Dark Forest Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Dark Forest Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-62,019	Closed	-$91.2K	–	1351
2025 Q1	$91.2K	Buy	62,019 +8,243	+15%	+$19.6K	﹤0.01%	1177
2024 Q4	$238K	Sell	53,776 -74,638	-58%	-$303K	0.04%	758
2024 Q3	$529K	Buy	128,414 +68,028	+113%	+$366K	0.07%	366
2024 Q2	$394K	Buy	60,386 +8,557	+17%	+$60.5K	0.07%	350
2024 Q1	$451K	Buy	+51,829	New	+$629K	0.08%	318
2023 Q4	–	Sell	-24,195	Closed	-$233K	–	783
2023 Q3	$233K	Buy	+24,195	New	+$237K	0.02%	977
2022 Q4	–	Sell	-117	Closed	-$1K	–	1313
2022 Q3	$1K	Buy	+117	New	+$1.33K	﹤0.01%	1052
2022 Q2	–	Sell	-102,785	Closed	-$1.29M	–	1119
2022 Q1	$1.29M	Buy	+102,785	New	+$1.18M	0.3%	76
2021 Q4	–	Sell	-1,119	Closed	-$15K	–	1597
2021 Q3	$15K	Buy	1,119 +386	+53%	+$4.99K	0.01%	897
2021 Q2	$9K	Buy	+733	New	+$8.39K	﹤0.01%	644

Other funds holding IRWD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dark Forest Capital Management's IRWD Position: Q2 2025 in Review

Dark Forest Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 62,019 shares — an estimated $91.2K sold.

Dark Forest Capital Management first reported a position in IRWD in Q2 2021 and held it in 10 quarters. The position peaked at $1.29M in Q1 2022. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

Dark Forest Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Dark Forest Capital Management sold 62,019 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $91.2K.
Dark Forest Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2021 and held it in 10 quarters.
Dark Forest Capital Management's Ironwood Pharmaceuticals position peaked at $1.29M in Q1 2022.
155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.